
Serac Healthcare has presented phase 2 data suggesting its investigational imaging agent, 99mTc-maraciclatide, may help distinguish active inflammation from fibrosis …
AstraZeneca is stopping two trials of a combination of two of its pipeline cancer treatments, after reports that the pairing …
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ

